Life Science Disruptors →
Partner at New Enterprise Associates
CEO and Fund Manager, Renaissance Venture Capital Fund
Co-Founder and CEO, DNAnexus
CEO of Project Foundry
Vice President for Research at UT Health Science Center at San Antonio
October 17, 2018 · Boston
November 4, 2018 · Boston
December 5, 2018 · San Francisco
November 5th, 2007
Boston Scientific (NYSE: BSX) announced it has sold its cardiac surgery and vascular surgery businesses to the Getinge Group for $750 million in cash. The Natick, MA-based firm first said it would sell the divisions back in August.
Xconomy Insight · Special Report
Get advice from the experts to help your biotech startup succeed
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2018, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.